AMAG Pharmaceuticals (AMAG)

Add to Watchlists
Create an Alert
17.88 +0.13  +0.73% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
AMAG Price Chart
View All Events

AMAG Events

Date Type Description
Feb 06 Misc AMAG Pharmaceuticals, Inc. Q4 2013 Earnings Conference Call
Feb 06 Earnings AMAG Pharmaceuticals, Inc. Q4 2013 Earnings Results. Estimate: -0.10.
Jan 13 Misc AMAG Pharmaceuticals Announces Preliminary Fourth Quarter and Annual 2013 Financial Results
Oct 23 Misc Q3 2013 AMAG Pharmaceuticals, Inc. Earnings Conference Call
Oct 23 Earnings Q3 2013 AMAG Pharmaceuticals, Inc. Earnings. Estimate: -0.11.
Aug 01 Misc Q2 2013 AMAG Pharmaceuticals, Inc. Earnings Conference Call
Aug 01 Earnings AMAG Pharmaceuticals, Inc. To Host Conference Call on August 1, 2013 at 8:00 a.m. Et to Discuss Financial Results for the Quarter Ended June 30, 2013. Estimate: -0.17.
Apr 23 Misc Q1 2013 AMAG Pharmaceuticals, Inc. Earnings Conference Call
Apr 23 Earnings AMAG Pharmaceuticals, Inc. To Host Conference Call on April 23, 2013 at 4:30 p.m. Et to Discuss Financial Results for the Quarter Ended March 31, 2013. Estimate: -0.20.
View All Performance Charts

AMAG Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AMAG Pharmaceuticals is down 14.78% over the last year vs S&P 500 Total Return up 22.72%, Actelion up 72.03%, and Isis Pharmaceuticals up 77.32%.

Get Quote for
Advertisement

Portfolio Strategies Featuring AMAG

Did AMAG Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AMAG Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

AMAG Pharmaceuticals, Inc., is a specialty pharmaceutical company that markets Feraheme® Injection for Intravenous, or IV, use to treat iron deficiency anemia, or IDA, and MuGard® Mucoadhesive Oral Wound Rinse for the management of oral mucositis.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AMAG 17.88 +0.13 +0.73% 389.29M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.